PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

NCT00499681 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Breast Cancer

Interventions

DRUG: lapatinib ditosylate
DRUG: letrozole
OTHER: placebo

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]